Etoricoxib versus placebo for knee osteoarthritis
How to Cite
OrthoEvidence. Etoricoxib versus placebo for knee osteoarthritis. ACE Report. 2018;7(5):20. Available from: https://myorthoevidene.com/AceReport/Report/10003
Fourteen days of etoricoxib 60 mg improves pain, hyperalgesia and physical function in individuals with knee osteoarthritis: a randomized controlled trialOsteoarthritis Cartilage. 2017 Nov;25(11):1781-1791
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
86 patients with symptomatic knee osteoarthritis were randomized to etoricoxib 60mg daily for 14 days or placebo for 14 days. Patients were assessed for outcome related to resting and dynamic pain, stiffness, function, and pressure pain threshold after 4 and 14 days of treatment. Results demonstrated significantly greater improvement after 14 days in the etoricoxib group compared to the placebo gr...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE